The Impact of Epitranscriptomics on Antiviral Innate Immunity

Viruses. 2022 Jul 28;14(8):1666. doi: 10.3390/v14081666.

Abstract

Epitranscriptomics, i.e., chemical modifications of RNA molecules, has proven to be a new layer of modulation and regulation of protein expression, asking for the revisiting of some aspects of cellular biology. At the virological level, epitranscriptomics can thus directly impact the viral life cycle itself, acting on viral or cellular proteins promoting replication, or impacting the innate antiviral response of the host cell, the latter being the focus of the present review.

Keywords: IFN-I response; RIG-I sensing; antiviral immunity; epitranscriptomics; viral infection.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents* / pharmacology
  • DEAD Box Protein 58 / metabolism
  • Immunity, Innate / genetics
  • Signal Transduction / genetics
  • Virus Replication* / genetics

Substances

  • Antiviral Agents
  • DEAD Box Protein 58

Grants and funding

The authors acknowledge the support from the Swiss National Science Foundation SNF314730_188877 and Novartis Foundation for Medical-Biological Research 21C149.